NCT04076579 2025-08-29Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic SarcomaUniversity of Michigan Rogel Cancer CenterPhase 2 Completed29 enrolled 13 charts
NCT03233204 2024-12-11Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)National Cancer Institute (NCI)Phase 2 Completed6 enrolled 12 charts